메뉴 건너뛰기




Volumn 19, Issue 17-19, 2001, Pages 2221-2226

Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults

Author keywords

Children; Influenza; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; LIVE VACCINE; NON PRESCRIPTION DRUG; TRIPLE VACCINE;

EID: 0035925590     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00449-7     Document Type: Conference Paper
Times cited : (83)

References (14)
  • 8
    • 0028893571 scopus 로고
    • Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: Importance of interferon-γ production and local IgA response
    • (1995) Vaccine , vol.13 , pp. 185-190
    • Tomoda, T.1    Morita, H.2    Kurashige, T.3
  • 11
    • 0033913482 scopus 로고    scopus 로고
    • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
    • (2000) J Pediatr , vol.136 , pp. 168-175
    • Belshe, R.B.1    Gruber, W.C.2    Mendelman, P.M.3
  • 14
    • 0032702094 scopus 로고    scopus 로고
    • Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    • (2000) Vaccine , vol.18 , pp. 899-906
    • Treanor, J.J.1    Kotloff, K.2    Betts, R.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.